Research output per year
Research output per year
Research output
Search results
-
2023
First survival data from the NIPU trial: A randomised, openlabel, phase II study evaluating nivolumab and ipilimumab combined with UV1 vaccination as second-line treatment in patients with malignant mesothelioma
Helland, A., Haakensen, V. D., Ojlert, A. K., Thunold, S. M. H., Nowak, A. K., Chin, W. L., Grundberg, O., Farooqi, S. J., Lund-Iversen, M., Szejniuk, W. M., Perez, S. M. C., Sørensen, J. B. & Bjaanaes, M. M., Oct 2023, In: Annals of Oncology. 34, Suppl. 2, p. S1337 1 p., LBA99.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
-
Inter-expert observer variance of organs at risk according to the DAHANCA guidelines
Jensen, K., Lorentzen, E., Eriksen, J. G., Johansen, J., Gyldenkerne, N., Zukauskaite, R., Kjellgren, M., Andersen, E., Maare, C., Lønkvist, C. K., Nowicka-Matus, K., Szejniuk, W., Farhadi, M., Ujmajuridze, Z., Marienhagen, K., Johansen, T. S., Kristensen, B. S., Friborg, J., Overgaard, J. & Hansen, C. R., May 2023, In: Radiotherapy and Oncology. 182, Suppl. 1, p. S582-S584 3 p., MO-0713.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
-
2020
BAP1 loss predicts longer survival for mesothelioma patients treated with pemetrexed-based chemotherapy
Panou, V., Louw, A., Szejniuk, W. M., Meristoudis, C., Chai, S. M., Lynggård Andersen, L., Birbaneh Asghari, A., Vyberg, M., Hansen, J., Creaney, J. & Røe, O. D., 7 Sept 2020, In: European Respiratory Journal. 56, suppl 64, 4490.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review